Opportunities for life expectancy prognosis to specify indications for lung transplantation in IFA patients
Abstract
The aim of this work was to determine the optimal period for lung transplantation in idiopathic fibrosing alveolitis (IFA) patients.
Retrospective analyze of 134 patients’ medical cards was performed. The patients (29 males and 105 females) met principal requirements for lung transplant recipients. The average age of the patients was 43 years, the mean life expectancy of 55 died was 30.26±4.3 months. The patients underwent chest X-ray examination, electrocardiography, echocardiograhy, angiopulmonography, lung function testing, and blood gas analyze.
The mean life expectancy in nonspecific interstitial pneumonia patients was noted to be reliably shorter, than in those with usual interstitial pneumonia (16.6±5.3 vs 30.9±9.2 months, p<0.01). The life expectancy did not depend on the patients’ age, the lung diffusing capacity parameters, breathlessness, pulmonary artery pressure, arterial blood carbon dioxide tension, gender, and length of the disease. A reverse linear relation was shown between the life expectancy and a functional degree of chronic cor pulmonale. A probability of lethal outcome during 1.5 years abruptly increased if p02 level reduced less than 60 mmHg. Thus, a complex dynamic evaluation of right heart parameters can be a criterion for identification of the optimal period for lung transplantation in such the patients.
About the Authors
T. A. Fedorova
НИИ пульмонологии СПбГМУ им. акад. И.П.Павлова; Институт аналитического приборостроения РАН
Russian Federation
Russian Federation
P. K. Yablonsky
НИИ пульмонологии СПбГМУ им. акад. И.П.Павлова; Институт аналитического приборостроения РАН
Russian Federation
Russian Federation
A. L. Bulyanina
НИИ пульмонологии СПбГМУ им. акад. И.П.Павлова; Институт аналитического приборостроения РАН
Russian Federation
Russian Federation
N. I. Alexandrova
НИИ пульмонологии СПбГМУ им. акад. И.П.Павлова; Институт аналитического приборостроения РАН
Russian Federation
Russian Federation
M. M. IIkovich
НИИ пульмонологии СПбГМУ им. акад. И.П.Павлова; Институт аналитического приборостроения РАН
Russian Federation
Russian Federation
L. N. Novikova
НИИ пульмонологии СПбГМУ им. акад. И.П.Павлова; Институт аналитического приборостроения РАН
Russian Federation
Russian Federation
E. V. Simonenko
НИИ пульмонологии СПбГМУ им. акад. И.П.Павлова; Институт аналитического приборостроения РАН
Russian Federation
Russian Federation
T. A. Stepanenko
НИИ пульмонологии СПбГМУ им. акад. И.П.Павлова; Институт аналитического приборостроения РАН
Russian Federation
Russian Federation
References
1. Большее Л.Н., Смирнов И.В. Таблицы математической статистики. М.: Наука; 1983.
2. Демидович Б.П., Марон И.А., Шувалова Э.З. Численные методы анализа / Под ред. Б. П. Демидовича. М.: Физматгиз; 1963.
3. Егурнов И.И., Александров А.Л., Семенова Л.А., Веселова Е.В. Исходы ИФА и их связь с показателями легочной гемодинамики и дыхания. Пробл. туб. 1987; 7: 10-12.
4. Илькович М.М. Идиопатический фиброзирующий альвеолит. В кн. Палеев H. Р. (ред.) Болезни органов дыхания. М.: Медицина ; 1990; т. 4: 64-89.
5. Левашев Ю.Н., Яблонский П.К., Ст епаненко Т.А. и др. Отбор реципиентов для трансплантации легких. Пульмонология 1998; 1: 56-64.
6. Сильвест ров В.П., Суворов Ю.А., Семин С.И., Марциновский В.Ю. Хроническое легочное сердце: механизмы формирования и прогрессирования. Тер. арх. 1990; 3: 103-108.
7. Agusti С., Xaubet A., Agusti A.G.N. et al. Clinical and functional assessment of patients with idiopathic pulmonary fibrosis: results of a 3 year follow-up. Eur. Respir. J. 1994; 7 (4): 643-650.
8. D'Armini A.M., Callegari G., Vitulo P. et al. Risk factors for early death in patients awaiting heart-lung or lung transplantation. Transplantation 1998; 66 (1): 123-127.
9. Grossman R.F., Frost A., Zamel N. et al. Results of single-lung transplantation for bilateral pulmonary fibrosis. N. Engl. J. Med. 1990; 322 (11): 727-733.
10. Harari S., Simonneau G., De Juli E. et al. Prognostic value of pulmonary hypertension in patients with chronic interstitial lung disease referred for lung or heart-lung transplantation. J. Heart Lung Transplant. 1997; 16 (4): 460-463.
11. Katzenstein A.-L. A., Myers J.L. Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. Am. J. Respir. Crit. Care Med. 1998; 157 (4, pt 1): 1301-1315.
12. Mapel D.W., Hunt W.C., Utton R. et al. Idiopathic pulmonary fibrosis: survival in population-based and hospital-based cohorts. Thorax 1998; 53 (6): 469-476.
13. Panos R.J., Mortenson R.L., Niccoli A., King T.E. Jr. Clinical deterioration in patients with idiopathic pulmonary fibrosis: causes and assessment. Am. J. Med. 1990; 88 (4): 396-404.
14. Turner-Warwick М., Burrows B., Johnson A. Cryptogenic fibrosing alveolitis: clinical features and their influence on survival. Thorax 1980; 35: 171-180.
15. Watters L.C., King T.E. et al. A clinical, radiographic and physiologic scoring system for the longitudinal assessment of patients with idiopathic pulmonary fibrosis. Am. Rev. Respir. Dis. 1986; 133 (1): 97-103.
Review
For citations:
Fedorova T.A., Yablonsky P.K., Bulyanina A.L., Alexandrova N.I., IIkovich M.M., Novikova L.N., Simonenko E.V., Stepanenko T.A. Opportunities for life expectancy prognosis to specify indications for lung transplantation in IFA patients. PULMONOLOGIYA. 2001;(2):25-30. (In Russ.)
Views:
179
Email this article 